Anhao, Mark Lesther P.
HRN: 22-36188 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/03/2023
07/09/2023
IV
85mg
Q8h
Age With Mod Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes